Eating fish and seafood with higher levels of mercury may be linked to a higher risk of amyotrophic lateral sclerosis (ALS), according to a preliminary study released today that will be presented at the American Academy of ...
Feb 20, 2017
0
185
(Medical Xpress) -- Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a universally fatal neurodegenerative disease. Mutations in two related proteins, TDP-43 and FUS, cause some forms of ALS. Specifically, ...
Nov 15, 2011
0
0
The Food and Drug Administration (FDA) recently approved the first new medication for ALS (amyotrophic lateral sclerosis) in five years—despite uncertainty about how much it helps patients with the progressive and devastating ...
Oct 18, 2022
0
12
New research published today out of the University of Calgary's Hotchkiss Brain Institute (HBI) uncovers a mechanism to promote growth in damaged nerve cells as a means to restore connections after injury. Dr. Doug Zochodne ...
Apr 22, 2014
0
0
Researchers from the University of Sheffield's Institute for Translational Neuroscience are involved in an ambitious European research project aimed at finding a new treatment for motor neurone disease (MND).
Jun 26, 2015
0
120
The Xrp1 protein appears to play an important role in the development of certain forms of ALS and dementia caused by a mutation in the FUS gene. This finding of Radboud University researchers was published on September 12th ...
Sep 14, 2018
0
24
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...
Jan 19, 2018
0
175
A much-debated drug for Lou Gehrig's disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.
Sep 30, 2022
0
8
Digoxin, a medication used in the treatment of heart failure, may be adaptable for the treatment of amyotrophic lateral sclerosis (ALS), a progressive, paralyzing disease, suggests new research at Washington University School ...
Oct 26, 2014
0
0
"Understanding Pseudobulbar Affect," the inaugural publication of the new Insights & Implications in Gerontology series from The Gerontological Society of America, addresses an often overlooked or misunderstood condition ...
Aug 11, 2022
0
21
